patent.fyi
Applications  /  US 2026/0354994
United States Patent Application Publication

US 2026/0354994 A1

Published
Nov 12, 2026
Filed
Dec 12, 2025
Earliest date on the face
May 26, 2020
Classification
A61F 2/844
First published here
Nov 19, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

No entries.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Coated stent in a flow loop

A benchtop blood compatibility system holds an expandable stent inside a flexible tube with a roughened test section. A coating on the stent carries a direct factor Xa inhibitor and a direct factor IIa inhibitor. A pump circulates blood through the tube while upstream and downstream sampling ports provide samples for measuring inhibitor release and thrombin generation.

Component substitution

Porous polyester sleeve as drug carrier

An electrospun polycaprolactone sleeve replaces a directly applied drug coating on an expandable stent. The sleeve sits on the outer face of the stent lattice and attaches at both ends with polymer sutures. The fibers carry a direct factor Xa inhibitor and a direct factor IIa inhibitor, which diffuse into surrounding fluid as it wets the sleeve.

Separate films for independent release rates

Two polymer films replace a single coating that contains both inhibitors. A hydrated polyethylene glycol film on the inward-facing strut surfaces carries the direct factor IIa inhibitor, and a polycaprolactone film on the outward-facing surfaces carries the direct factor Xa inhibitor. Separate coating passes set the film thicknesses independently, and each film releases its inhibitor by diffusion into fluid on its side of the lattice.

Parameter or scale variation

Three axial bands with graded loading

An 18 mm stent carries three adjacent 6 mm coating bands that span its length. The center band aligns with the injury and contains twice the mass of each inhibitor per unit coated area as either end band. All three bands use the same polymer and nominal dry thickness. Both inhibitors diffuse from each band after fluid wets the coating.

Combination with existing systems

Drug eluting stent on a balloon

A balloon catheter carries an expandable lattice with a direct factor Xa inhibitor and a direct factor IIa inhibitor on its outward-facing strut surfaces. The lattice crimps over the folded balloon between two radiopaque markers. Balloon inflation expands the lattice against the injured segment, and deflation allows catheter withdrawal while the coating releases both inhibitors locally.

Automated or data-driven variant

Vision guided placement of drug droplets

A camera maps the outward-facing struts of a stent mounted on a rotary stage. Software converts the strut map into dispensing coordinates and synchronizes stage rotation with a piezoelectric head that deposits a polymer solution containing both direct inhibitors. A second image locates gaps in the wet coating, and the head deposits additional droplets at those locations before drying.

Cite aspatent.fyi, US 2026/0354994 A1, claim 1, first published 2026-11-19T06:40:31-05:00, https://patent.fyi/US20260354994/, SHA-256 af68dca0fd88951606aa5aac7475377628a7cc83352c0ac19f99148c42990f0d
First published
Permanent addresshttps://patent.fyi/US20260354994/
Content fingerprint (SHA-256)af68dca0fd88951606aa5aac7475377628a7cc83352c0ac19f99148c42990f0d
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi